Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2

被引:180
|
作者
Higginbottom, A
Quinn, ER
Kuo, CC
Flint, M
Wilson, LH
Bianchi, E
Nicosia, A
Monk, PN
McKeating, JA
Levy, S [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2UH, S Yorkshire, England
[3] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England
[4] IRBM, I-00040 Pomezia, Rome, Italy
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.74.8.3642-3649.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human CD81 has been previously identified as the putative receptor for the hepatitis C virus envelope glycoprotein E2. The large extracellular loop (LEL) of human CD81 differs in four amino acid residues from that of the African green monkey (AGM), which does not bind E2, We mutated each of the four positions inhuman CD81 to the corresponding AGM residues and expressed them as soluble fusion LEL proteins in bacteria or as complete membrane proteins in mammalian cells. We found human amino acid 186 to be critical for the interaction,vith the viral envelope glycoprotein, This residue was also important for binding of certain anti-CD81 monoclonal antibodies, Mutating residues 188 and 196 did not affect E2 or antibody binding. Interestingly, mutation of residue 163 increased both E2 and antibody binding, suggesting that this amino acid contributes to the tertiary structure of CD81 and its ligand-binding ability. These observations have implications for the design of soluble high-affinity molecules that could target the CD81-E2 interaction site(s).
引用
收藏
页码:3642 / 3649
页数:8
相关论文
共 50 条
  • [41] Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
    Heo, Tae-Hwe
    Lee, Song-Mi
    Bartosch, Birke
    Cosset, Francois-Loic C.
    Kang, Chang-Yuil
    VIRUS RESEARCH, 2006, 121 (01) : 58 - 64
  • [42] Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2-CD81 interaction
    Bhattacharjee, Chayan
    Nandy, Suman K.
    Das, Pratik
    Mukhopadhyay, Aparna
    INFECTION GENETICS AND EVOLUTION, 2019, 69 : 48 - 60
  • [43] CD81 is required for hepatitis C virus glycoprotein-mediated viral infection
    Zhang, J
    Randall, G
    Higginbottom, A
    Monk, P
    Rice, CM
    McKeating, JA
    JOURNAL OF VIROLOGY, 2004, 78 (03) : 1448 - 1455
  • [44] Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells
    Mazzocca, A
    Sciammetta, SC
    Carloni, V
    Cosmi, L
    Annunziato, F
    Harada, T
    Abrignani, S
    Pinzani, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) : 11329 - 11339
  • [45] Is CD81 the key to hepatitis C virus entry?
    Maher, J
    DeLeve, L
    Crabb, D
    DiBisceglie, A
    Keeffe, E
    Lavine, J
    Nathanson, M
    Rockey, D
    Thiele, D
    HEPATOLOGY, 1999, 29 (03) : 990 - 992
  • [46] CD81 is an entry coreceptor for hepatitis C virus
    Cormier, EG
    Tsamis, F
    Kajumo, F
    Durso, RJ
    Gardner, JP
    Dragic, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (19) : 7270 - 7274
  • [47] Hepatitis C virus entry and the tetraspanin CD81
    Farquhar, Michelle J.
    Harris, Helen J.
    McKeating, Jane A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 532 - 536
  • [48] CD81 and Hepatitis C Virus (HCV) Infection
    Feneant, Lucie
    Levy, Shoshana
    Cocquerel, Laurence
    VIRUSES-BASEL, 2014, 6 (02): : 535 - 572
  • [49] Hepatitis C Virus E2 Envelope Glycoprotein Induces an Immunoregulatory Phenotype in Macrophages
    Kwon, Young-Chan
    Meyer, Keith
    Peng, Guangyong
    Chatterjee, Soumya
    Hoft, Daniel F.
    Ray, Ranjit
    HEPATOLOGY, 2019, 69 (05) : 1873 - 1884
  • [50] Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor
    Wünschmann, S
    Medh, JD
    Klinzmann, D
    Schmidt, WN
    Stapleton, JT
    JOURNAL OF VIROLOGY, 2000, 74 (21) : 10055 - 10062